Corcept Therapeutics, Inc. (CORT)
114.58
+1.23
(+1.09%)
USD |
NASDAQ |
Sep 01, 12:01
Corcept Therapeutics Net Income (TTM) : 54.20M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.20M |
| March 31, 2026 | 46.67M |
| December 31, 2025 | 98.16M |
| September 30, 2025 | 104.65M |
| June 30, 2025 | 131.98M |
| March 31, 2025 | 132.49M |
| December 31, 2024 | 139.71M |
| September 30, 2024 | 140.46M |
| June 30, 2024 | 124.94M |
| March 31, 2024 | 117.18M |
| December 31, 2023 | 105.47M |
| September 30, 2023 | 90.87M |
| June 30, 2023 | 94.25M |
| March 31, 2023 | 94.30M |
| December 31, 2022 | 101.29M |
| September 30, 2022 | 116.81M |
| June 30, 2022 | 112.73M |
| March 31, 2022 | 111.84M |
| December 31, 2021 | 112.51M |
| September 30, 2021 | 106.45M |
| June 30, 2021 | 97.61M |
| March 31, 2021 | 99.41M |
| December 31, 2020 | 106.01M |
| September 30, 2020 | 109.40M |
| June 30, 2020 | 114.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 105.97M |
| December 31, 2019 | 94.18M |
| September 30, 2019 | 86.81M |
| June 30, 2019 | 78.22M |
| March 31, 2019 | 76.22M |
| December 31, 2018 | 75.41M |
| September 30, 2018 | 151.73M |
| June 30, 2018 | 147.74M |
| March 31, 2018 | 142.19M |
| December 31, 2017 | 129.12M |
| September 30, 2017 | 35.39M |
| June 30, 2017 | 24.22M |
| March 31, 2017 | 12.55M |
| December 31, 2016 | 8.14M |
| September 30, 2016 | 4.502M |
| June 30, 2016 | 1.316M |
| March 31, 2016 | -1.597M |
| December 31, 2015 | -6.408M |
| September 30, 2015 | -11.26M |
| June 30, 2015 | -16.67M |
| March 31, 2015 | -22.28M |
| December 31, 2014 | -31.38M |
| September 30, 2014 | -38.61M |
| June 30, 2014 | -43.51M |
| March 31, 2014 | -47.86M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Liquidia Corp. | 138.61M |
| Eli Lilly & Co. | 26.71B |
| Abeona Therapeutics, Inc. | -62.89M |
| Indivior Pharmaceuticals, Inc. | 355.00M |
| Crinetics Pharmaceuticals, Inc. | -501.61M |